2000
DOI: 10.1292/jvms.62.473
|View full text |Cite
|
Sign up to set email alerts
|

The Evaluation of the Potential of Botulinum C3 Enzyme as an Exogenous Differentiation Inducing Factor to Neurons.

Abstract: ABSTRACT. Botulinum C3 enzyme produced by Clostridium botulinum type C and D strains modifies Rho proteins. In a previous study, we observed that the LDH isozyme pattern of neurons treated with C3 enzyme was different from that induced with endogenous growth factor of neurons such as NGF [21]. This type of change is considered to have an advantage in the medical use of C3 enzyme for neural disorder. To determine the functional similarity of C3-treated neurons to control and NGF-treated neurons, we examined the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2002
2002
2005
2005

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…This process brings about a variety of cellular changes, some of which are morphological: adherent cells`round up' (Chardin et al, 1989), monocytes spread out (Aepfelbacher et al, 1996) and neuronal PC12 cells exhibit neurite outgrowth (Rubin et al, 1988). C3bot1 also stimulates the regeneration of injured axons in vivo (Lehmann et al, 1999), highlighting its potential for the treatment of certain neural disorders (Watanabe et al, 2000). However, the role of C3 exoenzymes in the pathogenesis of bacterial disease is unclear because of the lack of an obvious cell-entry mechanism.…”
Section: Introductionmentioning
confidence: 99%
“…This process brings about a variety of cellular changes, some of which are morphological: adherent cells`round up' (Chardin et al, 1989), monocytes spread out (Aepfelbacher et al, 1996) and neuronal PC12 cells exhibit neurite outgrowth (Rubin et al, 1988). C3bot1 also stimulates the regeneration of injured axons in vivo (Lehmann et al, 1999), highlighting its potential for the treatment of certain neural disorders (Watanabe et al, 2000). However, the role of C3 exoenzymes in the pathogenesis of bacterial disease is unclear because of the lack of an obvious cell-entry mechanism.…”
Section: Introductionmentioning
confidence: 99%
“…These functions of Rho are sufficient to explain the distinctive morphological changes observed after the addition of C3bot1 to the cytosol of cells. These changes are specific to cell type, and the observation that neuronal PC12 cells exhibit neural outgrowth (12) and experiments showing that C3bot1 can cause regeneration of injured axons in vivo (13) suggested a possible usefulness in treating neuronal disorders (14).…”
mentioning
confidence: 99%
“…C3 exoenzyme evoked the outgrowth of neurites from a chicken ganglion [7] and induced acetylcholinesterase activity in PC12 cells [15], NG108-15, and C6 cell lines [8]. The primary culture cells of mouse cerebrum treated with C3 exoenzyme showed a response similar to that of the control matured cells against various drugs such as muscarine, and acetylcholine as a neurotransmitter [21]. These observations then indicate that C3 exoenzyme is regarded as a kind of neurotropic factor.…”
mentioning
confidence: 99%